Concr
PrivateLast Round
Grant
Feb 9, 2024
Total Funding Raised
$4.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Concr is a techbio company that provides a predictive modelling platform, FarrSight®, to enhance confidence and foresight about the therapeutic efficacy of existing and emerging cancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concr Comparables
Compare Concr with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 81% | |
| InSilicoTrials Technologies | 80% | |
| Epigene Labs | 79% | |
Concr Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 9, 2024 | ||||
| Seed | Nov 29, 2023 | ||||
| Seed | Mar 31, 2023 |
Key People
Founding team and executive leadership
Concr Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Deep Science Ventures | Seed |
| Cambridge Angels | Seed |
| Cambridge Enterprise | Seed |
| R42 Group | Seed |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 85% MoM.
- Feb 9, 2024
$1.26M grant awarded by Innovate UK
Concr Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Concr's valuation, stock price, and market status.